04 Aug, 16:14 - Indian

SENSEX 81018.72 (0.52)

Nifty Midcap 100 57432.35 (1.40)

Nifty IT 35203.35 (1.60)

Nifty Smallcap 100 17893.4 (1.27)

Nifty 50 24722.75 (0.64)

Nifty Bank 55619.35 (0.00)

Nifty Next 50 66917.5 (1.09)

Nifty Pharma 22153.8 (0.65)

04 Aug, 16:14 - Global

NIKKEI 225 40290.7 (-1.25)

HANG SENG 24733.46 (0.92)

S&P 6313.5 (0.59)

LOGIN HERE

companylogoKimia Biosciences Ltd

You are Here : Home > Markets > CompanyInformation > Board Meeting
BSE Code : 530313 | NSE Symbol : | ISIN : INE285U01025 | Industry : Pharmaceuticals - Indian - Bulk Drugs |


Board Meeting
Announcement Date Date Of Meeting Purpose Detail
20-Jun-2025 25-Jun-2025 EGM Intimation Of Board meeting under regulation 29(1)(d) of SEBI (LODR)Regulation,2015 INTIMATION FOR THE APPOINTMENT OF COST AUDITOR FOR THE FINANCIAL YEAR 2025-2026 AS PER REGULATION 30 OF SEBI(LODR) REGULATIION 2015 INTIMATION FOR THE APPOINTMENT OF ADDITIONAL DIRECTOR INTIMATION FOR THE APPOINTMENT OF SECRETARIAL AUDITOR FOR THE FINANCIAL YEAR 2024-2025 Intimation about the appointment of Cost Auditor of the company for the financial year 2025-2026. (As per BSE Announcement Dated on 25/06/2025)
21-May-2025 26-May-2025 Accounts Kimia Biosciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/05/2025 inter alia to consider and approve approval of audited financials for the quarter and financial year ended on 31st march 2025 Outcome of the Financials in the Board Meeting (As Per BSE Announcement Dated on 26.05.2025) Revised Document for the quarter and financial year ended on 31st March,2025(Regulation 30 and 33 of the SEBI(Listing Obligation and Disclosure Requirement)Regulation,2015 (As Per BSE Announcement Dated on: 12.06.2025)
01-May-2025 05-May-2025 Preferential Issue Kimia Biosciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/05/2025 inter alia to consider and approve Intimation for the Board Meeting to be held on Monday 05th May 2025 for the Payment to Redeemable Preference Shares. Pursuant to Regulation 30 read with Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Board of Directors of Kimia Biosciences Limited at its meeting held today, i.e., Monday, 05th May 2025, inter alia, considered and approved the matter, Redemption of Preference Shares. (As Per BSE Announcement Dated on:05.05.2025)
19-Apr-2025 23-Apr-2025 Change in Auditors Kimia Biosciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/04/2025 inter alia to consider and approve The change in auditor of the company. outcome of Board Meeting ,where the board has approved and consider the appointment of statutory auditor to fill the casual vacancy and also the resignation of Chief Finance Officer. INTIMATION UNDER REGULATION 30 OF SEBI (LISTING OBLIGATION AND DISCLOSURE RQUIREMENTS). (As Per BSE Announcement Dated on 23.04.2025)
07-Feb-2025 13-Feb-2025 Quarterly Results Kimia Biosciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2025 inter alia to consider and approve Intimation of Board Meeting for approving quarter and nine months ended on December 31 2024 to be held on February 13 2025. Approval of unaudited Financial Results for the quarter and none months ended December 31, 2024 along with Limited review report (As Per BSE Announcement Dated on: 13/02/2025)
29-Nov-2024 05-Dec-2024 AGM Kimia Biosciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/12/2024 inter alia to consider and approve Intimation for Board Meeting to approve Directors Report and AGM Notice for the FY ended March 31 2024. The meeting of Board of Directors of the Company was held today on Thursday, December 5, 2024 at 4.00 pm (IST) at the corporate office of the Company, situated at 974, 9th Floor, Aggarwal Millennium Tower-II, Netaji Subash Place, New Delhi-110034 and the following businesses, amongst others, were transacted at the meeting of the Board of Directors. 1. The Board of Directors considered and approved the Director's Report and Notice of forthcoming Annual General Meeting of the Company to be held on 28th December,2024 .The Annual General Meeting of the company will be held on 28th December,2024 at 4:00pm(IST) through Video Conferencing ('VC')/Other Audio-Visual Means('OAVM') Revised outcome (As per BSE Announcement Dated on 05/12/2024)
12-Nov-2024 14-Nov-2024 Quarterly Results Kimia Biosciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2024 inter alia to consider and approve Notice is hereby given pursuant to Regulation 29 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 that a meeting of the Board of Directors of the Company is scheduled to be held on Thursday the 14th day of November 2024 to inter-alia consider approve and take on record the Un- Audited Financial Results of the Company for the Second Quarter (Q2) and Half year ended September 30 2024 of the Financial Year 2024-25 duly reviewed (Limited Review) by the Statutory Auditors of the Company. 1. Approval of un-audited financial results of the Company, on standalone basis, as at/for the quarter and three months ended September 30th 2024, in accordance with Regulation 33 of SEBI (Listing Obligation and Disclosure) Requirements) Regulations, 2015 and taking on record the Limited Review Report issued by the Statutory Auditor of the Company (copy attached as Annexure A). 2. Appointment of Mrs. Pallavi Garg (ACS- 69848) as the Company Secretary & Compliance Officer of the Company. (As per BSE Announcement dated on 14/11/2024)
06-Aug-2024 14-Aug-2024 Quarterly Results Kimia Biosciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2024 inter alia to consider and approve This is to inform that a meeting of Board of Directors is scheduled to be held on Wednesday August 14 2024 at 03.00 pm (IST) at the corporate office of the Company 974 9th Floor Aggarwal Millennium Tower-II Netaji Subhash Place Pitampura New Delhi-110034 to transact the following businesses amongst others: 1) To consider and approve the un-audited financial results on standalone basis of the Company for quarter and three months ended June 30 2024 in accordance with Regulation 33 of SEBI (Listing Obligation and Disclosure Requirements) Regulations 2015; 2) Any other matter as may be considered and transacted with permission of Board of Directors. Unaudited Quarterly Financial Results for the Quarter Ended on 30th June,2024. (As Per BSE Announcement dated on 20.08.2024)
22-Jun-2024 28-Jun-2024 Change in Auditors Kimia Biosciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/06/2024 inter alia to consider and approve This is to inform that a meeting of Board of Directors is scheduled to be held on Friday June 28 2024 at 12.00 pm (IST) at the corporate office of the Company 974 9th Floor Aggarwal Millennium Tower-II Netaji Subhash Place Pitampura New Delhi-110034 to transact the following businesses amongst others: 1) To consider and short listing the firm for appointment of Statutory Auditors of the Company arose due to casual vacancy. 2) Any other matter as may be considered and transacted with permission of Board of Directors. Dear Sir/Madam, The meeting of Board of Directors of the Company was held today on Friday, June 28, 2024 at 12.00 pm (IST) at the corporate office of the Company, situated at 974, 9th Floor, Aggarwal Millennium Tower-II, Netaji Subash Place, New Delhi-110034 and the following businesses, amongst others, were transacted at the meeting of the Board of Directors. 1. Appointment of Sunil Suresh & Associates, Chartered Accountants as Statutory Auditors of the Company to fill the casual vacancy on the recommendation of the Audit Committee. The Appointment is subject to the approval of shareholders at the ensuing Annual General Meeting of the Company Dear Sir/ Madam, Pursuant to Regulation 30 of the SEBI (Listing Obligation and Disclosure Requirement) Regulations, 2015, the Board of Directors of the Company at their meeting held on June 28, 2024 on the recommendation of the Audit Commitee, inter alia considered and subject to the approval of the shareholders at the ensuing Annual General Meeting approved the appointment of Sunil Suresh & Associates, Chartered Accountants as the Statutory Auditors of the Company to fill the casual vacancy of the Company (As per BSE Announcement Dated on 28/06/2024)
21-May-2024 30-May-2024 Accounts Kimia Biosciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2024 inter alia to consider and approve Dear Sir/ Madam This is to inform you that a meeting of Board of Directors is scheduled to be held on Thursday May 30 2024 at 4.00 pm at the corporate office of the Company 974 9th Floor Aggarwal Millenium Tower Netaji Subash Place New Delhi-110034. 1) To consider and approve the audited financial results on standalone basis of the Company for quarter and year ended March 31 2024 in accordance with Regulation 33 of SEBI ( Listing Obligation and Disclosure Requirements) Regulations 2015. The Company refer to our earlier submission of the audited standalone financial results for the quarter and year ended March 31, 2024, which was filed on 30.05.2024. It has come to the attention that the declaration of an unmodified opinion was inadvertently missed out due to technical snag during the filing process. We deeply regret this insight and any inconvenience it may have caused. Please find attached complete set of audited standalone financial results for the quarter and year ended March 31, 2024, including declaration of unmodified opinion. You are requested to kindly take this in your records. Read less.. (As Per BSE Announcement Dated on 14.06.2024) Outcome of Board Meeting under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015. Dear Sir/Madam, The meeting of Board of Directors of the Company was held today on Thursday, May 30, 2024 at 4.00 pm (IST) at the corporate office of the Company, situated at 974, 9th Floor, Aggarwal Millennium Tower-II, Netaji Subash Place, New Delhi-110034 and the following businesses, amongst others, were transacted at the meeting of the Board of Directors. 1. Approval of audited financial results of the Company, on standalone basis, as at/for the year ended March 31, 2024, in accordance with Regulation 33 of SEBI (Listing Obligation and Disclosure) Requirements) Regulations, 2015 and taking on record the Limited Review Report issued by the Statutory Auditor of the Company (copy attached as Annexure A). 2. Appointment of Rahul Chaudhary & Associates, Company Secretaries as Secretarial Auditor for conduct of Secretarial for the financial year 2024-25. (As Per BSE Announcement dated on 30.05.2024)
07-Feb-2024 14-Feb-2024 Quarterly Results Kimia Biosciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2024 inter alia to consider and approve Dear Sir/Madam This is to inform that a meeting of Board of Directors is scheduled to be held on Wednesday February 14 2024 at 3:00 pm (IST) at the corporate office of the Company 974 9th Floor Aggarwal Millennium Tower-II Netaji Subhash Place Pitampura New Delhi-110034 to transact the following businesses amongst others: i. To consider and approve the un-audited financial results on standalone basis of the Company for quarter and nine months ended December 31 2023 in accordance with Regulation 33 of SEBI (Listing Obligation and Disclosure Requirements) Regulations 2015; The meeting of the Board of Directors was held on Wednesday, February 14, 2024 at 3:00 pm (IST), and the following businesses, amongst others, were transacted thereat: 1. Approval of un-audited financial results, on standalone basis, of the Company for the quarter and nine months ended December 31, 2023 in accordance with Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and taking on record the Limited Review Report of the Auditors on the same (copy attached as Annexure A) (As per BSE Announcement Dated on 14/02/2024)
01-Nov-2023 09-Nov-2023 Quarterly Results Kimia Biosciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/11/2023 inter alia to consider and approve This is to inform that a meeting of Board of Directors is scheduled to be held on Thursday November 09 2023 at 04.00 pm (IST) at the corporate office of the Company 974 9th Floor Aggarwal Millennium Tower-II Netaji Subhash Place Pitampura New Delhi-110034 to transact the following businesses amongst others: 1) To consider and approve the un-audited financial results on standalone basis of the Company for quarter and half year ended September 30 2023 in accordance with Regulation 33 of SEBI (Listing Obligation and Disclosure Requirements) Regulations 2015; 2) Any other matter as may be considered and transacted with permission of Board of Directors. The meeting of Board of Directors of the Company was held today on Thursday, November 09, 2023 at 4.00 pm (IST) at the corporate office of the Company, situated at 974, 9th Floor, Aggarwal Millennium Tower-II, Netaji Subash Place, New Delhi-110034 and the following businesses, amongst others, were transacted at the meeting of the Board of Directors. 1. Approval of un-audited financial results of the Company, on standalone basis, as at/for the half year ended September 30th 2023, in accordance with Regulation 33 of SEBI (Listing Obligation and Disclosure) Requirements) Regulations, 2015 and taking on record the Limited Review Report issued by the Statutory Auditor of the Company (copy attached as Annexure A). You are requested to take the above information on record and disseminate the same on your website. The meeting was concluded at 7.00 pm. Comments of Board of Directors. (As Per BSE Announcement dated on 09.11.2023)
07-Sep-2023 07-Sep-2023 Change in Other Executives Pursuant to Regulation 30 of the SEBI (LODR) 2015, it is informed that Board of Directors in its meeting held today i.e. 7 september 2023, approved the appointment of Mr. Rakesh Chetani as Chief Financial Officer & Key Managerial Personnel of the Company
05-Sep-2023 05-Sep-2023 AGM The meeting of Board of Directors of the Company was held today on Tuesday, September 5, 2023 at 4.00 p.m. (IST) at the corporate office of the Company situated at 974, 9'' floor Aggarwal Millennium Tower-II Netaji Subhash Place Pitampura Delhi-110034 to transact the business thereat: The Board of Directors of the Company in its meeting held on September05, 2023, decided to convene the 30th AGM of the Company. (As Per BSE Announcement Dated on 09/09/2023)
07-Aug-2023 14-Aug-2023 Quarterly Results Kimia Biosciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2023 inter alia to consider and approve This is to inform that a meeting of Board of Directors is scheduled to be held on Monday August 14 2023 at 4.00 pm (IST) at the corporate office of the Company 974 9th Floor Aggarwal Millennium Tower-II Netaji Subhash Place Pitampura New Delhi-110034 to transact the following businesses amongst others Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements ) Regulations, 2015 and Para A of Part A of schedule III, this is to inform you that the Board of Directors of the Company at its meeting held today 14.08.2023 has inter alia considered the following: The meeting of Board of Directors of the Company was held today on Monday, August 14, 2023 at 4.00 pm (IST) at the corporate office of the Company, situated at 974, 9th Floor, Aggarwal Millennium Tower-II, Netaji Subash Place, New Delhi-110034 and the following businesses, amongst others, were transacted at the meeting of the Board of Directors. (As Per BSE Announcement dated on 14.08.2023)
1 2 3 

Capital Market Publishers India Pvt. Ltd

401, Swastik Chambers, Sion Trombay Road, Chembur, Mumbai - 400 071, India.

Formed in 1986, Capital Market Publishers India Pvt Ltd pioneered corporate databases and stock market magazine in India. Today Capitaline corporate database cover more than 35,000 listed and unlisted Indian companies. Latest technologies and standards are constantly being adopted to keep the database user-friendly, comprehensive and up-to-date.

Over the years the scope of the databases has enlarged to cover economy, sectors, mutual funds, commodities and news. Many innovative online and offline applications of these databases have been developed to meet various common as well as customized requirements.

While all the leading institutional investors use Capitaline databases, Capital Market magazine gives access to the databases to individual investors through Corporate Scoreboard. Besides stock market and company-related articles, the magazine’s independent and insightful coverage includes mutual funds, taxation, commodities and personal finance.

Copyright @ Capital Market Publishers India Pvt.Ltd

Designed, Developed and maintained by CMOTS Infotech (ISO 9001:2015 Certified)

Site best viewed in Internet Explorer Edge ,   Google Chrome 115.0.5790.111 + ,   Mozilla Firefox 115.0.3 + ,   Opera 30.0+, Safari 16.4.1 +